Results 111 to 120 of about 5,480 (216)

Efficacy and safety of Xeligekimab (GR1501) in the treatment of axial Spondyloarthritis: Results from a Phase II clinical trial. [PDF]

Rheumatol Immunol Res
Zeng X, Zhang S, Liu H, Zhao Y, Li X, Jiang Z, Xue Y, Kong N, Sun L, Liu S, Fan X, Hu J, Shen L, Xu D.   +13 more
europepmc   +1 more source

The course of aberrant findings on MRI of the sacroiliac joints over 6 months in postpartum women [PDF]

, 2019
Carron, Philippe, De Craemer, Ann-Sophie, de Hooge, Manouk, Dehaene, Isabelle, Depicker, Anaïs, Deroo, Liselotte, Elewaut, Dirk, Herregods, Nele, Jans, Lennart, Renson, Thomas, Roelens, Kristien, Van den Bosch, Filip, Varkas, Gaëlle   +12 more
core   +1 more source

The value of EQ-5D-3L and EQ VAS as a patient-reported outcome measure for patients with ankylosing spondylitis in routine healthcare: an evaluation of construct validity and responsiveness based on the Swedish Rheumatology Quality Register. [PDF]

J Patient Rep Outcomes
Degerlund-Maldi K, Regardt M, Nystrand Länsman C, Larsson L, Parodis I, Heintz E.   +5 more
europepmc   +1 more source

Impact of symptom duration on the short- and long-term efficacy of bimekizumab in axial spondyloarthritis: results up to 2 years. [PDF]

Arthritis Res Ther
Ramiro S, Proft F, Sengupta R, van Tubergen A, Moltó A, Gensler LS, Kishimoto M, Taieb V, Kavanagh S, Evans S, Navarro-Compán V.   +10 more
europepmc   +1 more source

Correlation Between Serum Procalcitonin and Disease Activity Score in Patients with Ankylosing Spondylitis That Have Hip Involvement. [PDF]

Int J Gen Med
Liang X, Deng B.
europepmc   +1 more source

Psychometric validation of the Bulgarian Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire: linking quality of life with disease activity in axial spondyloarthritis. [PDF]

BMC Rheumatol
Pencheva DT, Johnstone E, Grzeda MT, Boyadzhieva V, Stoilov N, Ivanova M.   +5 more
europepmc   +1 more source

Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study. [PDF]

Sci Rep
Gentileschi S, Terribili R, Gaggiano C, Fiorentini E, Cometi L, Cigolini C, Perrotta FM, Scriffignano S, Di Cato L, Panaccione A, Niccoli L, Cantini F, Benucci M, Li Gobbi F, Delle Sedie A, Vitale A, Lubrano E, Frediani B, Guiducci S.   +18 more
europepmc   +1 more source

Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study. [PDF]

Rheumatology (Oxford)
Poddubnyy D, Sieper J, Akar S, Muñoz-Fernández S, Haibel H, Protopopov M, Altmaier E, Ganz F, Inman RD.   +8 more
europepmc   +1 more source

Coping with rheumatic stressors in long-standing axial spondyloarthritis: association with patient and disease characteristics. [PDF]

Rheumatology (Oxford)
van Essen M, Capelusnik D, van der Heijde D, Landewé RBM, van Lankveld W, van Tubergen A, Ramiro S, Boonen A.   +7 more
europepmc   +1 more source

Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. [PDF]

, 2015
Cantini F, Conversano M, Delogu G, Garlaschi G, Goletti D, Iannone F, Matucci A, Nannini C, Niccoli L, Prignano F, SAFEBIO, SANDUZZI ZAMPARELLI, ALESSANDRO   +11 more
core   +1 more source